Efficacy of lamivudine plus adefovir therapy or adefovir add on therapy for entecavir-resistant hepatitis B patients.
Phase of Trial: Phase IV
Latest Information Update: 02 Sep 2016
At a glance
- Drugs Adefovir (Primary) ; Entecavir (Primary) ; Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 18 Jan 2012 Actual patient number (37) added as reported by ClinicalTrials.gov.
- 18 Jan 2012 Status changed from active, no longer recruiting to completed as reported by Korean Clinical Trials Register.
- 13 Sep 2011 New trial record